Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Felbamate

An anti-epileptic of the dicarbamate family, approved in the United States in July 1993. Today it is reserved for hard-to-control epilepsy, such as partial seizures that do not respond to other treatments and Lennox-Gastaut syndrome in children. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?When it arrived it was presented as the first major new anti-epileptic introduced in the United States in over fifteen years, and it opened a season of new drugs against epilepsy.

FelbamateGo to the active ingredient →
FelbamateActive ingredientFelbamateCat. No. P-F013-001CAS 25451-15-4
Felbamate-d4Isotopically labelledFelbamate-d4Cat. No. P-F013-004CAS 106817-52-1
Felbamate-d5Isotopically labelledFelbamate-d5Cat. No. P-F013-005CAS 1191888-51-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.